MedTrace Logo

Can Patient Expectations Influence Pain Reduction After Epidural Injections in Patients With Low Back Pain?

NCT05402631 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2022-10-03

No results posted yet for this study

Summary

Investigators hypothesize that patients with higher expectations regarding their epidural injection experience a higher pain reduction of their lower back pain and/or leg pain after an epidural injection. Patients' expectations of an epidural injection can influence their level of pain reduction. The primary objective of this study is to investigate the prognostic significance of patient expectations on pain reduction after epidural injections ('expected benefits', see under) in patients with low back pain and/or leg pain.

Investigators furthermore hypothesize that patients that have a higher match between their expectations of improvement and actual improvement are more satisfied. A secondary objective of this study is to investigate the prognostic significance of a high match between expectations of improvement and actual improvement on patient satisfaction of the treatment.

Conditions

  • Expectations
  • Back Pain
  • Back Pain Lower Back Chronic
  • Satisfaction, Patient
  • Injections, Epidural
  • Injections, Periradicular
  • Pain, Back

Interventions

PROCEDURE

Epidural Injection

patient receives an epidural injection due to lower back pain

PROCEDURE

Periradicular Injection

patient receives a periradicular injection due to lower back pain

Sponsors & Collaborators

  • Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland

    collaborator UNKNOWN

  • Ospedale Regionale di Lugano

    lead OTHER

Principal Investigators

  • Eva Koetsier, PhD · Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland

  • Valeria Scheiwiller · Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano, Switzerland

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-04-20
Primary Completion
2022-09-30
Completion
2022-09-30

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05402631 on ClinicalTrials.gov